fda alert
fda alert
07/28/2023

Leigh Precopio

Leigh Precopio
The FDA has examined the results of a recent confirmatory trial to verify the clinical benefit of an amyloid beta-directed antibody for the treatment of Alzheimer disease.
07/28/2023
FDA Alert
FDA Alert
05/15/2023

Jessica Ganga

Jessica Ganga
Following two 12-week studies, the FDA has approved the first ever medication for treating agitation in patients with dementia due to Alzheimer disease.
05/15/2023
FDA Roundup
FDA Roundup
07/28/2015

Anthony Calabro, MA

Anthony Calabro, MA
This FDA Roundup includes an at-a-glance look at the latest FDA drug approvals in June and July, including the first over-the-counter, nonprescription daily oral contraceptive, the first monoclonal...
07/28/2015